Pfizer expects updated COVID-19 vaccine data for kids under 5 by April

AMMAN—Pfizer Inc (PFE.N) expects the latest results from a clinical trial for kids under the age of 5 of the COVID-19 vaccine it developed with Germany's BioNTech SE by April, a top company scientist said, according to the Jordan News Agency, Petra. اضافة اعلان

"The study has been amended to give a third dose to everybody who's less than five at least eight weeks after their last vaccination," Dr. Alejandra Gurtman, a Pfizer vaccine researcher said at a meeting of the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP).

She said the company aims to have data for the age group by the end of March or the beginning of April.

Read more Region and World news.